目的回顾性分析联合肝脏分割和门静脉结扎的二步肝切除术(associating liver partition and portal vein ligation for staged hepatectomy,ALPPS)后早期复发情况的原因。方法选取2014年6月~2016年6月接受ALPPS或射频消融辅助ALPPS(radi...目的回顾性分析联合肝脏分割和门静脉结扎的二步肝切除术(associating liver partition and portal vein ligation for staged hepatectomy,ALPPS)后早期复发情况的原因。方法选取2014年6月~2016年6月接受ALPPS或射频消融辅助ALPPS(radiofrequencyablationassistedALPPS,RALPPS)治疗的12例患者为研究对象。对患者的肝功能、Child-Pugh评分、病灶、肝脏分割程度、术后无病生存时间、总生存时间等指标进行回顾性分析。结果阶段-1ALPPS后,FLR体积从(333.7±54.1)mL增加至(577.1±83.7)mL,差异有统计学意义(P<0.001)。阶段-1和阶段-2之间的间隔为:完全性ALPPS为(10.0±1.6)d,部分性ALPPS为(31.3±5.2)d,差异有统计学意义(P<0.001)。术后90d内死亡率为0%(0/12),Clavien-Dindo并发症分级为Ⅰ~Ⅲa。术后3、6个月和12个月复发率分别为16.7%(2/12)、83.3%(10/12)和100.0%(12/12);平均DFS时间为(4.5±0.6)个月,平均生存时间为(9.0±0.7)个月,中位随访时间为11.0个月。结论ALPPS以及RALPPS术后患者易出现早期复发。手术创伤、部分性ALPPS过长的FLR再生时间、肝实质的不完全分割、肿瘤细胞的不完全消融等均可能是术后早期复发的原因。展开更多
Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulati...Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a dosed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.展开更多
文摘目的回顾性分析联合肝脏分割和门静脉结扎的二步肝切除术(associating liver partition and portal vein ligation for staged hepatectomy,ALPPS)后早期复发情况的原因。方法选取2014年6月~2016年6月接受ALPPS或射频消融辅助ALPPS(radiofrequencyablationassistedALPPS,RALPPS)治疗的12例患者为研究对象。对患者的肝功能、Child-Pugh评分、病灶、肝脏分割程度、术后无病生存时间、总生存时间等指标进行回顾性分析。结果阶段-1ALPPS后,FLR体积从(333.7±54.1)mL增加至(577.1±83.7)mL,差异有统计学意义(P<0.001)。阶段-1和阶段-2之间的间隔为:完全性ALPPS为(10.0±1.6)d,部分性ALPPS为(31.3±5.2)d,差异有统计学意义(P<0.001)。术后90d内死亡率为0%(0/12),Clavien-Dindo并发症分级为Ⅰ~Ⅲa。术后3、6个月和12个月复发率分别为16.7%(2/12)、83.3%(10/12)和100.0%(12/12);平均DFS时间为(4.5±0.6)个月,平均生存时间为(9.0±0.7)个月,中位随访时间为11.0个月。结论ALPPS以及RALPPS术后患者易出现早期复发。手术创伤、部分性ALPPS过长的FLR再生时间、肝实质的不完全分割、肿瘤细胞的不完全消融等均可能是术后早期复发的原因。
文摘Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a dosed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.